Clinical Trial

CORonary Thrombus Modification to Prevent MIcrovascular Damage in Patients With ST-segment Elevation Myocardial Infarction (The CORMI Trial)

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate the effects of coronary thrombus modification on preventing the microvascular damage associated with primary percutaneous coronary intervention (PCI), and to limit the associated myocardial damage assessed by myocardial salvage index after 3 months. Furthermore, the project will evaluate coronary microvascular damage assessed invasively using both continuous and bolus thermodilution before and after stent implantation. In addition, the project will evaluate the diagnostic ability and associations of pre-stenting invasive physiological measurement to cardiac magnetic resonance imaging measurements.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-12.
Trial Details
NCT Number NCT07646977
Lead Sponsor Odense University Hospital
Conditions ST Elevation Myocardial Infarction, Coronary Microvascular Dysfunction, Percutaneous Coronary Intervention
Enrollment 100 participants
Start Date 2026-06
Primary Completion 2029-03 (estimated)
Study Completion 2034-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-24